ADCT News and Press, ADC Therapeutics SA

2026-03-27 12:15:54 ET ADC Therapeutics SA (ADCT) Discusses ZYNLONTA Strategy, Clinical Progress, and Sales Growth Outlook March 24, 2026 12:00 PM EDT... Read the full article on Seeking Alpha For further details see: ADC Therapeutics SA (ADCT) Discusses ZYNLONTA Strategy, C...

2026-03-10 10:00:59 ET More on ADC Therapeutics ADC Therapeutics SA (ADCT) Q4 2025 Earnings Call Transcript ADC Therapeutics SA (ADCT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript ADC Therapeutics posts preliminary 2025 revenue of about $73M ...

2026-03-10 10:00:18 ET ADC Therapeutics SA (ADCT) Q4 2025 Earnings Call March 10, 2026 8:30 AM EDT Company Participants Nicole Riley - Head of Investor Relations & Corporate Communications Ameet Mallik - CEO & Director Jose Carmona - Chief Financial Officer...

2026-03-10 07:31:59 ET More on ADC Therapeutics ADC Therapeutics SA (ADCT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript ADC Therapeutics posts preliminary 2025 revenue of about $73M Seeking Alpha’s Quant Rating on ADC Therapeutics ...

ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update PR Newswire LOTIS-5 Phase 3 topline data expected in second quarter 2026, with full data for LOTIS-5 and LOTIS-7 anticipated by year-end 2026 Recent amendment to HealthCa...

Blend Labs Inc. Class A (BLND) is expected to report $-0.02 for Q4 2025 United Natural Foods Inc. (UNFI) is expected to report $0.51 for Q2 2026 Consumer Portfolio Services Inc. (CPSS) is expected to report $0.23 for Q4 2025 Westrock Coffee Company (WEST) is expected to report $-0.1 f...

2026-03-09 10:26:53 ET More on ADC Therapeutics ADC Therapeutics SA (ADCT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript ADC Therapeutics posts preliminary 2025 revenue of about $73M Seeking Alpha’s Quant Rating on ADC Therapeutics ...

ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026 PR Newswire LAUSANNE, Switzerland , March 3, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody...

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire LAUSANNE, Switzerland , March 2, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced t...

ADC Therapeutics to Participate in March Investor Conferences PR Newswire LAUSANNE, Switzerland , Feb. 24, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced par...